浩宇生醫 6872

Key Points A new clinical trial is testing the use of NaviFUS’s neuronavigation-guided focused ultrasound system for the treatment of patients with drug-resistant epilepsy. The study is being led by Professor Terence O’Brien, a specialist in neurology and clinical pharmacology at Alfred Health in Melbourne, Australia.   Current anti-seizure medications are not effective for all patients ...